Abbreviated Company Accounts - MERLIN NEURORESEARCH G LTD.

Abbreviated Company Accounts - MERLIN NEURORESEARCH G LTD.


Registered Number 03301413

MERLIN NEURORESEARCH G LTD.

Abbreviated Accounts

31 January 2016

MERLIN NEURORESEARCH G LTD. Registered Number 03301413

Abbreviated Balance Sheet as at 31 January 2016

Notes 2016 2015
£ £
Fixed assets
Tangible assets 2 824 1,099
824 1,099
Current assets
Stocks - 22,597
Debtors 21,831 150
21,831 22,747
Creditors: amounts falling due within one year (144,325) (61,682)
Net current assets (liabilities) (122,494) (38,935)
Total assets less current liabilities (121,670) (37,836)
Total net assets (liabilities) (121,670) (37,836)
Capital and reserves
Called up share capital 3 2 2
Profit and loss account (121,672) (37,838)
Shareholders' funds (121,670) (37,836)
  • For the year ending 31 January 2016 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 29 October 2016

And signed on their behalf by:
Mr R T Hanbury, Director

MERLIN NEURORESEARCH G LTD. Registered Number 03301413

Notes to the Abbreviated Accounts for the period ended 31 January 2016

1Accounting Policies

Basis of measurement and preparation of accounts
The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective January 2015).

Tangible assets depreciation policy
Depreciation has been provided at the following rates to write off the assets over their useful estimated lives.
Plant and machinery 25% reducing balance basis

Other accounting policies
Research and Development
The company is undertaking research and has produced a prototype for a wearable device to aid sleep. Research and development expenditure is written off as incurred.

Foreign currency
Transactions in foreign currencies are recorded at the exchange rate ruling at the date of the transaction. At the balance sheet date, monetary items denominated in foreign currencies are translated at the rate prevailing at the balance sheet date. All exchange rate differences are included in the profit and loss account.

2Tangible fixed assets
£
Cost
At 1 February 2015 26,265
Additions -
Disposals -
Revaluations -
Transfers -
At 31 January 2016 26,265
Depreciation
At 1 February 2015 25,166
Charge for the year 275
On disposals -
At 31 January 2016 25,441
Net book values
At 31 January 2016 824
At 31 January 2015 1,099
3Called Up Share Capital
Allotted, called up and fully paid:
2016
£
2015
£
2Ordinary shares of £1 each 2 2